MCAP.ST Stock — Price, Charts & Analysis

MedCap AB (publ) (MCAP.ST) has a trailing P/E of 34.80x and a forward P/E of 110.45x. This places MCAP.ST in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

MCAP.ST trades with 34.80x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether MCAP.ST looks overvalued or undervalued.

MCAP.ST's P/E of 34.80x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

MCAP.ST's trailing EPS is SEK 16.09 and forward EPS is SEK 5.07. Reported earnings growth is 28.80%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit MedCap AB (publ) generated for each share. MCAP.ST's trailing EPS is SEK 16.09, and investors usually prefer EPS that is positive and growing over time.

MedCap AB (publ) has a market cap of SEK 8.39B, making MCAP.ST a mid-cap stock based on the current market value shown on Worldtickers.

MCAP.ST's latest stock price on Worldtickers is SEK 560.00. The latest move is SEK 9.00 or 1.63%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

MCAP.ST's quote includes a latest price of SEK 560.00. The market open is SEK 551.50. Previous close is SEK 551.00. The intraday range is SEK 551.50 to SEK 563.00.

MCAP.ST is up in the latest quote, with a move of SEK 9.00 or 1.63%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

MCAP.ST generated SEK 2.26B in trailing revenue. Revenue growth is 16.20%, which helps show whether demand is expanding or slowing.

MCAP.ST's revenue growth is 16.20%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, MCAP.ST shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is SEK 240.60M.

Gross margin is 59.38%. Margins show how efficiently MedCap AB (publ) turns revenue into profit.

MedCap AB (publ) carries SEK 457.60M and holds SEK 286.30M in cash.

MCAP.ST holds SEK 286.30M on its balance sheet.

MCAP.ST's book value per share is SEK 105.91.

Institutions hold 53.15% of MCAP.ST shares. Insiders hold 20.91% of shares. Ownership mix helps investors understand how much of MedCap AB (publ) is held by professional investors and company insiders.

MCAP.ST has 14.98M shares outstanding. Float shares are 11.83M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for MCAP.ST, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for MCAP.ST is SEK 5.07. Earnings growth is 28.80%. Revenue growth is 16.20%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

MCAP.ST's trailing EPS is SEK 16.09. Forward EPS is SEK 5.07. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

MCAP.ST is in the Healthcare sector. Its earnings multiple is 34.80x. Its latest displayed growth metric is 16.20%. Compare these figures with sector peers before deciding whether MedCap AB (publ) is stronger or weaker than average.

MCAP.ST trades at SEK 560.00. The stock trades at 34.80x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of MedCap AB (publ)'s fundamentals.

MCAP.ST risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.49, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

MCAP.ST should be compared with companies in Medical Devices. Its earnings multiple is 34.80x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

MedCap AB (publ) (MCAP.ST) operates in Healthcare, specifically Medical Devices. MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mob

MCAP.ST trades on Stockholm. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

MCAP.ST stock is priced in SEK on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

MedCap AB (publ)'s official website listed on Worldtickers is medcap.se/en. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

MedCap AB (publ) employs about 647 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

MedCap AB (publ) is headquartered in Stockholm, Sweden. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

MCAP.ST is in the Healthcare sector and the Medical Devices industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

MCAP.ST has traded between SEK 440.00 and SEK 670.00 over the past 52 weeks. At SEK 560.00, it is 16.42% below the high and 27.27% above the low. The 52-week range helps gauge long-term price momentum.

MCAP.ST is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is SEK 524.40 and its 200-day moving average is SEK 517.51.

MCAP.ST's RSI is 55.23. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

MCAP.ST's latest RSI reading is 55.23, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for MCAP.ST is near SEK 521.50. Key resistance is near SEK 582.00. Breaks above resistance or below support can change the short-term technical setup.

MCAP.ST's nearest reported support level is SEK 521.50. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

MCAP.ST's nearest reported resistance level is SEK 582.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

MCAP.ST trades about 15.93K shares daily on average. The latest displayed volume is 12.63K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

MCAP.ST's MACD is -0.47, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

MCAP.ST is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 55.23 (neutral). MACD is bearish. Nearest support is around SEK 521.50. Resistance is around SEK 582.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is SEK 547.90 (0.57% from price). MA50 is SEK 524.40 (5.07% from price). MA200 is SEK 517.51 (6.47% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. MCAP.ST's MA20 is SEK 547.90. MA50 is SEK 524.40. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

MCAP.ST's pivot is near SEK 549.50. Support is near SEK 521.50. Resistance is near SEK 582.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for MCAP.ST is near SEK 520.67. The next upper resistance zone is near SEK 571.25. These levels help define risk and possible follow-through zones after a breakout or breakdown.

MCAP.ST's Bollinger range is roughly SEK 526.47 to SEK 569.33. Band width is near 7.82%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

MCAP.ST's ATR-based typical daily range is about 2.99%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 12.63K shares. Average volume is about 15.93K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

MCAP.ST's all-time high shown on Worldtickers is SEK 677.00. Its all-time low is SEK 4.60. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

MCAP.ST has a beta of 0.49, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.